| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/16/2008 | US7425337 Alphavirus replicon vector systems |
| 09/16/2008 | US7425331 Protein A methods of use |
| 09/16/2008 | US7425325 binding ligands and proteins comprising amino acid sequences, having high specificity for the receptor zcytor17, used to induce proinflammatory cytokine production, for stimulating the immune system and proliferation and/or development of hematopoietic cells in vitro and in vivo; antibodies |
| 09/16/2008 | US7425292 Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
| 09/16/2008 | CA2480429C Novel therapeutical use of agonist ligands specific to g2a receptor |
| 09/16/2008 | CA2409748C Soluble ctla4 mutant molecules and uses thereof |
| 09/16/2008 | CA2379557C Arylsulphonamide-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 09/16/2008 | CA2292730C Stabilized antibody formulation |
| 09/16/2008 | CA2202470C Intracellular isoform of the interleukin-1-receptor antagonist |
| 09/16/2008 | CA2120732C Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction |
| 09/16/2008 | CA2102301C Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
| 09/12/2008 | WO2008109613A1 Benzo[c][2,7]naphthyridine derivatives, and their use as kinase inhibitors |
| 09/12/2008 | WO2008109314A1 Heterocyclic compounds, compositions comprising them and methods of their use |
| 09/12/2008 | WO2008108309A1 Fused pyridine derivative |
| 09/12/2008 | WO2008108284A1 Rankl production inhibitor |
| 09/12/2008 | WO2008108262A1 Immunomodulating agent |
| 09/12/2008 | WO2008107873A1 Mercaptopurine derivatives as anticancer agents |
| 09/12/2008 | WO2008107436A1 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions |
| 09/12/2008 | WO2008106979A2 Pharmaceutical compositions comprising flavonoids and xylitol |
| 09/12/2008 | WO2007113646B1 A pharmaceutical composition useful as an immunomodulating agent and a process for the preparation thereof |
| 09/12/2008 | WO2007103134A3 Prolongation of survival of an allograft by inhibiting complement activity |
| 09/12/2008 | WO2007073176A3 Composition comprising a polyunsaturated fatty acid for improving membrane composition |
| 09/12/2008 | CA2680227A1 Compositions and methods for the prevention and treatment of autoimmune conditions |
| 09/12/2008 | CA2679924A1 Milk-derived basic protein fraction for inhibiting rankl production |
| 09/12/2008 | CA2679743A1 Methods and compositions involving polymeric immunoglobulin fusion proteins |
| 09/12/2008 | CA2679700A1 Mercaptopurine derivatives as anticancer agents |
| 09/12/2008 | CA2679101A1 Heterocyclic compounds, compositions comprising them and methods of their use |
| 09/12/2008 | CA2678492A1 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions |
| 09/11/2008 | US20080221200 Dipeptidyl-peptidase (DPP) IV inhibitor N-peptidyl-O-aroyl hydroxylamine and immunosuppressor or immunomodulator; autoimmune diseases, graft rejection; antidiabetic agents; Alzheimer's, Parkinson's disease; obesity, retinopathy, nephropathy, neuropathy, schizophrenia; cognition activators |
| 09/11/2008 | US20080221189 Rosacea, psoriasis, acute inflammation, chronic inflammation, septic shock, an autoimmune disease |
| 09/11/2008 | US20080221186 4-(substituted cycloalkylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkenylmethyl) Imidazole-2-Thiones, 4-(substituted cycloalkylmethyl) Imidazol-2-Ones and 4-(substituted cycloalkenylmethyl) Imidazole-2-Ones and related compounds |
| 09/11/2008 | US20080221180 Thiazole Derivatives and Use Thereof |
| 09/11/2008 | US20080221131 Respiratory system disorders; asthma; chronic obstructive pulminary disease; antiproliferative agents; immunosuppressants |
| 09/11/2008 | US20080221103 4-(3-Methyl-2,5-dioxo-2,5-dihydro-1H-pyrrol-1-ylamino)-6-(methylthio)-2-phenylpyrimidine-5-carbonitrile; having significant in vitro TNF- alpha inhibitory activity useful for the treatment of various inflammatory diseases such as arthritis, inflammatory bowel disease, psoriasis, asthma, COPD, cancer etc. |
| 09/11/2008 | US20080221086 Novel Inhibitors of Glutaminyl Cyclase |
| 09/11/2008 | US20080221054 In vitro; transgenic cells, mammals; kits |
| 09/11/2008 | US20080221024 ShK toxin attached to an atom, molecule, group, residue, compound, moiety that has an anionic charge; multiple sclerosis, type-1 diabetes mellitus, rheumatoid arthritis and psoriasis |
| 09/11/2008 | US20080221017 Pharmaceutical or cosmetic composition and use of a PKC inhibitor with an MMP inhibitor for inhibiting langerhans cell migration |
| 09/11/2008 | US20080221016 Modulating Glucocorticoid Induced TNF Receptor with an agent that binds GITR; binding a fusion protein to a GITR ligand to modulate regulatory T cell function; Multiple Sclerosis, Insulin-Dependent Diabetes Mellitus, Inflammatory Bowel Disease, Ulcerative Colitis, Crohns Disease |
| 09/11/2008 | US20080220500 Expression vector comprising nucleotide sequences coding lipogenic enzyme for treatment and prevention of cardiovascular, inflammatory, nervous system, gastrointestinal and psychological disorders |
| 09/11/2008 | US20080220083 Pharmaceutical Agent Comprising Blood Components <10 Kda And Their Use For Prophylaxis And Treatment Of Defects Of The Immune System |
| 09/11/2008 | US20080220024 Antifungal vaccines with saccharomyces cerevisiae |
| 09/11/2008 | US20080220019 in a cell culture, for use as antibodies or vaccines against hepatitis virus; genetic engineering |
| 09/11/2008 | US20080220015 Method of modulating neutralizing antibodies formation in mammals, and uses thereof in gene therapy, animal trangenesis and in functional inactivation of endogenous proteins |
| 09/11/2008 | US20080220007 Ehrlichia canis genes and vaccines |
| 09/11/2008 | US20080220006 Method for Modulating Inflammatory Responses |
| 09/11/2008 | US20080220003 C5a Receptor Antagonists |
| 09/11/2008 | US20080220000 Methods for Generating Improved Immune Reponse |
| 09/11/2008 | US20080219990 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219988 Polypeptide comprising major histocompatibility complex epitopes for targeting and destroying tumor cells |
| 09/11/2008 | US20080219979 Using cytokine receptor specific immunoglobulin as therapeutic tool in treatment and prevention of inflammatory, nervous system, skin and autoimmune disorders |
| 09/11/2008 | US20080219974 Transmembrane glycoprotein specific immunoglobulin for use in diagnosis, prevention and treatment of autoimmune diseases |
| 09/11/2008 | US20080219958 Treating neuroblastoma in mammals via exposure to tumor antigen pulsed antigen-presenting cells; tissue targeted therapy; immunotherapy |
| 09/11/2008 | US20080219953 Cosmid dna constructs and methods of making and using same |
| 09/10/2008 | EP1967525A2 A method for regulating immune function in primates using the foxp3 protein |
| 09/10/2008 | EP1967523A1 New thiophen glycoside derivatives, method for their manufacture, medicines containing these compounds and their application |
| 09/10/2008 | EP1967520A2 Production of polyketides and other natural products |
| 09/10/2008 | EP1967519A1 3,4-dihydrobenzoxazine compound and inhibitor of vanilloid receptor type 1 (vr1) activity |
| 09/10/2008 | EP1967207A1 Inhibitor of cytotoxic t cell induction |
| 09/10/2008 | EP1967206A2 Anti-IgE vaccines |
| 09/10/2008 | EP1967205A2 Anti-IgE vaccines |
| 09/10/2008 | EP1967195A1 Antacid |
| 09/10/2008 | EP1966245A1 Anti-cd19 antibodies with reduced immunogenicity |
| 09/10/2008 | EP1966202A1 Heteroaryl substituted pyrroloý2,3-b¨pyridines and pyrroloý2,3-b¨pyrimidines as janus kinase inhibitors |
| 09/10/2008 | EP1966200A1 Heterocyclic janus kinase 3 inhibitors |
| 09/10/2008 | EP1966194A2 Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators |
| 09/10/2008 | EP1966165A1 Pyrazine derivatives as epithelial sodium channel blocker |
| 09/10/2008 | EP1966163A1 Pyrimidine derivatives useful as inhibitors of pkc-theta |
| 09/10/2008 | EP1965807A2 S1p receptor modulating compounds and use thereof |
| 09/10/2008 | EP1855692A4 Composition for reducing the exudation of serum proteins |
| 09/10/2008 | EP1451222B1 Proteins with il-6 inhibiting activity |
| 09/10/2008 | EP1441771B1 Aqueous sustained-release formulations of proteins |
| 09/10/2008 | EP1438053B1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same |
| 09/10/2008 | EP1427708B1 Amino-phthalazinone derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them |
| 09/10/2008 | EP1261337B1 Topoisomerase inhibitors for treatment of surgical adhesions |
| 09/10/2008 | EP1060247B1 Compositions containing an ox-40 receptor binding agent or a nucleic acid encoding the same and methods for enhancing antigen-specific immune response |
| 09/10/2008 | EP0983767B1 Preventives or remedies for the treatment of multiple sclerosis containing antagonist anti-IL-6-receptor antibodies |
| 09/10/2008 | CN101262875A Peptides capable of modulating the function of TIRC7 |
| 09/10/2008 | CN101262861A Pharmaceutical for use in prevention and/or treatment of bowel disease |
| 09/10/2008 | CN101260050A 氨基链烷醇衍生物 Amino alkanol derivative |
| 09/10/2008 | CN101259262A Inhalation for improving immunity and preparation thereof |
| 09/10/2008 | CN101259233A Traditional Chinese medicine preparation for improving adult chicken immunity and antioxidant ability |
| 09/10/2008 | CN101259180A Shenshe composition and preparation thereof |
| 09/10/2008 | CN101259177A Medicaments for treating chronic bronchitis and confecting method thereof |
| 09/10/2008 | CN101259171A Chinese medicine preparation for preventing piglingí»s yellow-white dysentery and improving immunity |
| 09/10/2008 | CN101259128A Polymorph medicine |
| 09/10/2008 | CN100417665C Method for preparing pollen pini polyose, pollen pipe polyose and its use in medicine |
| 09/10/2008 | CN100417659C Nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 09/10/2008 | CN100417391C Composition comprising soluble glucan oligomer from saccharomyces cerevisiae is2 for immune activation or prevention and treatment of cancer and the preparation method thereof |
| 09/10/2008 | CN100417390C Effective part of sweet wormwood, its preparation method and application thereof in pharmacy |
| 09/09/2008 | US7423057 Dihydroorotate dehydrogenase (DHODH) inhibitors; Rheumatoid arthritis, Pneumocystis carinii, fibrosis, uveitis, rhinitis, asthma, and athropathy; 2-(Biphenyl-4-ylcarbamoyl)-cyclopent-1-enecarboxylic acid |
| 09/09/2008 | US7423055 e.g., 2-(2-methyl-5-amino)phenyl-4-(3-pyridyl)-thiazole; c-kit inhibitors; treating cell proliferative, metabolic, allergic, and degenerative disorders. |
| 09/09/2008 | US7423049 e.g., 2-(5-fluoro-2-tolyl)-4-(4-aminocarbonylpiperazinylmethyl)-6-[a-aminocarbonyl-2,6-dichlorobenzyl]pyridine; mitogen-activated protein kinase inhibitor; antiinflammatory agent, autoimmune diseases |
| 09/09/2008 | US7423047 Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors |
| 09/09/2008 | US7423041 e.g. 3-[2-(4-Aminophenyl)ethyl]-8-benzyl-1-propylxanthine; A1-adenosine receptor antagonist; antiallergen, antiinflammatory agent; AIDS and immune deficiency disorders, asthma; good water solubility |
| 09/09/2008 | US7423023 Enhancement of immune response using targeting molecules |
| 09/09/2008 | US7423016 Genetic engineering; inducting immunology response |
| 09/09/2008 | US7423014 Insulin conjugates for treating diabetes mellitus |
| 09/09/2008 | US7423011 Treating autoimmune diseases such as multiple sclerosis with CXCR4 antagonist such as peptides having of stromal cell derived factor one (SDF-1) sequences |
| 09/09/2008 | US7422906 Apoptosis-inducing gene and utilization of the same |